ThirdWaveRx Funding, Investors & Competitors

ThirdWaveRx has raised $140M across 2 funding rounds, most recently a $20M undisclosed-stage round in October 2022.

Last ThirdWaveRx funding round

$20M

Undisclosed stage · Oct 2022

Cumulative funding ThirdWaveRx raised

$140M

across 2 funding rounds

Key investors in ThirdWaveRx

  • WindRose Health Investors

ThirdWaveRx Overview

About ThirdWaveRx

ThirdWaveRx is a pharmaceutical rebate management company handling PBM relationships and eligibility reviews. Founded in 2021 and headquartered in Las Vegas, Nevada, ThirdWaveRx helps healthcare organizations optimize their pharmaceutical spending through rebate optimization.


Founded

2021

HQ

United StatesLas Vegas, NV

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

ThirdWaveRx Funding History

ThirdWaveRx has raised a total of $140M across 2 funding rounds.

ThirdWaveRx's first fundraising round was a $120M undisclosed-stage round in September 2022. The most recent completed round was a $20M undisclosed-stage round in October 2022.

ThirdWaveRx funding rounds

ThirdWaveRx funding rounds
DateStageInvestorsRaisedDeal Summary
Oct 2022Undisclosed stage-$20M-
Sep 2022Undisclosed stageWindRose Health Investors (lead)$120MThird Wave Recovery Systems (TWRx), based in Las Vegas, is a provider of rebate administration services for hospitals, long-term care (LTC) facilities, and select specialty physician groups. On September 16, 2022, WindRose Health Investors, a New York-based healthcare private equity firm, completed an investment in TWRx, pursuing control equity in healthcare services including outsourced services to payors and health systems. In conjunction with WindRose's investment, TWRx acquired SRX, LLC, a New York-based leader in pharmaceutical rebate management for the skilled nursing and LTC industry. The combined entity appointed a new executive team led by CEO Ed Lagerstrom, formerly President of UnitedHealthcare Networks, with co-founder Eric Moskow, M.D., transitioning to Chairman and remaining a significant shareholder. WindRose Partner Alex Buzik highlighted the acquisition as cementing TWRx as the premier platform in rebate and prescription drug management. WindRose's investment aims to support TWRx's strong momentum and rapid growth in the rebate administration marketplace through industry knowledge and relationships. The firm, founded in 2000, targets technology-enabled services and healthcare providers.

Who has invested in ThirdWaveRx?

1 investor has backed ThirdWaveRx across its funding rounds, including WindRose Health Investors.

Lead investors include WindRose Health Investors.


ThirdWaveRx Investors

Investors in ThirdWaveRx by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 1 ThirdWaveRx investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by ThirdWaveRx

ThirdWaveRx has acquired 1 company to date.

Last acquisition by ThirdWaveRx was on September 14th 2022. ThirdWaveRx acquired SRX for undisclosed valuation.


Latest Acquisitions by ThirdWaveRx

SRX
Description
SRX is a software platform for long-term care and skilled nursing facilities that automates rebate eligibility, formulary checks, and compliance with pharmacy integrations. The technology connects electronic health records, drug databases, and facility protocols to streamline medication management. SRX serves U.S. healthcare providers by reducing administrative burdens in rebate processing and regulatory reporting.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date14 Sep 2022
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ThirdWaveRx acquisitions and their M&A valuation multiples.

Start Free Trial

ThirdWaveRx Competitors

ThirdWaveRx competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.

Public and private companies comparable to ThirdWaveRx
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$44B3.4x
VeevaUnited StatesUnited StatesPublicly listed$3.2B$965M$43B10.2x
IDEXX LaboratoriesUnited StatesUnited StatesPublicly listed$4.3B$1.5B$40B8.9x
Roper TechnologiesUnited StatesUnited StatesPublicly listed$7.9B$3.2B$37B5.7x
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x
DoctolibFranceParisPrivate$400M-$6.4B16.0x

ThirdWaveRx Public Comps

ThirdWaveRx is still privately-owned, but its public comps include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging, Glaukos and M3 Inc..

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x
Roper Technologies$7.9B$3.2B6.1x5.7x15.2x14.6x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x
ICON plc$8.3B$816M1.9x1.9x19.2x11.3x
Pro Medicus$186M$147M66.6x62.7x84.4x77.6x
United Imaging$2.1B$367M5.5x4.8x30.7x26.9x

This data is available for Pro users. Sign up to see all ThirdWaveRx competitors and their valuation data.

Start Free Trial

Common questions about ThirdWaveRx

When was ThirdWaveRx founded?ThirdWaveRx was founded in 2021.
Where is ThirdWaveRx headquartered?ThirdWaveRx is headquartered in Las Vegas, NV, United States.
Is ThirdWaveRx publicly listed?No, ThirdWaveRx is a private, VC-backed company.
How much funding has ThirdWaveRx raised?ThirdWaveRx has raised $140M across 2 funding rounds.
What was ThirdWaveRx's last funding round?ThirdWaveRx's last funding round was a $20M undisclosed-stage round in October 2022.
Who are ThirdWaveRx's investors?ThirdWaveRx's investors include WindRose Health Investors.
Which companies are comparable to ThirdWaveRx?Companies comparable to ThirdWaveRx include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib.
How many companies has ThirdWaveRx acquired?ThirdWaveRx has acquired 1 company, including SRX.

See companies similar to ThirdWaveRx

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial